Abstract:Background: Fontan physiology leads to chronic changes in other organ systems that may affect long-term survival and the success of heart transplantation. Inadequate assessment and treatment of the extra-cardiac effects of Fontan may contribute to poor outcomes. Severity-graded/ordinal consensus definitions of Fontan complications are lacking, which limits understanding of how Fontan-specific morbidity affects patients' outcomes. Methods and results: A panel of Fontan patient and physiology experts, including pediatric, adult congenital, heart failure, and critical-care cardiology as well as pediatric nephrology, hepatology and psychology, convened to develop definitions of Fontan complications. Definitions were created by using a severity-graded ordinal scale: grade 1, mild; grade 2, moderate; grade 3, severe; grade 4, disabling or life threatening. Following definition creation, a second panel of 21 experts in Fontan circulatory failure used a modified Delphi methodology to modify and vote on definitions until consensus (> 90% agreement without recommended further modification) was reached on final definitions. After 3 rounds of modifications and voting, consensus agreement was achieved on all Fontan-specific definitions. The defined complications and morbidities of Fontan include: anatomic Fontan pathway obstruction, cyanosis, systemic venous abnormalities resulting from venous insufficiency, atrial arrhythmia, ventricular arrhythmia, bradycardia, chronic pleural effusions, chronic ascites, protein-losing enteropathy, plastic bronchitis, hemoptysis and pulmonary hemorrhage, sleep apnea, Fontan-associated liver disease, portal and hepatic variceal disease, acute kidney injury affecting clinical treatment, polycythemia, thrombotic disease, recurrent or severe bacterial infection, skin atrophy, adrenal insufficiency, physical impact of previous stroke, mood/behavior disorder, and neurodevelopmental disorder. Conclusion: Consensus and severity-graded definitions of Fontan-specific cardiac and extra-cardiac complications were achieved and are available for use in research. They will allow future robust analyses of Fontan patient outcomes.

Contemporary Management of the Failing Fontan

Complications and management of functional single ventricle patients with Fontan circulation: From surgeon's point of view

Invasive Hemodynamic Evaluation of the Fontan Circulation: Current Day Practice and Limitations

Morbidity and mortality in adults with a Fontan circulation beyond the fourth decade of life

Evaluating the Longevity of the Fontan Pathway

Transcatheter Interventions in Adults With Fontan Palliation

Incidence, pathophysiology, and treatment of failing Fontan after the total cavopulmonary connection

Management of People With a Fontan Circulation: a Cardiac Society of Australia and New Zealand Position statement

Contemporary Provider Management Practices and Attitudes Toward Referral for Advanced Heart Failure Therapies in Fontan Patients Across North America

The Current Strategy in Managing Congenital and Structural Heart Disease: Find and Treat Them Appropriately

Protocols associated with no mortality in 100 consecutive Fontan procedures

Surgical Considerations in Adult Congenital Heart Disease Heart Failure

Clinical Application of Extracardiac Conduit Fontan Procedure

Novel Therapeutic Strategies in Heart Failure in Adult Congenital Heart Disease: of Medicines and Devices

Mid-term results and late events after the Fontan operation: A single-center experience

Nutritional considerations for people living with a Fontan circulation: a narrative review

Use of Pulmonary Arterial Hypertension Therapies in Patients with a Fontan Circulation: Current Practice Across the United Kingdom

Achieving Consensus: Severity-Graded Definitions of Fontan-Associated Complications to Characterize Fontan Circulatory Failure

Management of Fallot's Uncorrected Tetralogy in Adulthood: A Narrative Review

Fontan Completion in Adult Patients with Functionally Univentricular Hearts

Target Flow-Pressure Operating Range for Designing a Failing Fontan Cavopulmonary Support Device